RECRUITING

Are Portable Lactate Monitoring Devices Accurate in Patients with Glycogen Storage Disease Ia When Compared to Blood Serum Lactates?

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, in a population of patients with glycogen storage disease type 1a.

Official Title

Are Portable Lactate Monitoring Devices Accurate in Patients with Glycogen Storage Disease Ia When Compared to Blood Serum Lactates?

Quick Facts

Study Start:2025-03-10
Study Completion:2026-03-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06843330

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:0 Years to 60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia (ICD 10 code: E74.01).
  2. * Connecticut Children's Emergency Department visit and/or admission to Connecticut Children's during time study is active
  3. * For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document
  4. * For adults: Ability to understand and the willingness to sign a written informed consent
  1. * Patients with Glycogen storage disease unspecified 74.00, or Ib
  2. * Patients not meeting inclusion criteria

Contacts and Locations

Study Contact

Rebecca Riba-Wolman, MD
CONTACT
860-837-6700
rriba@connecticutchildrens.org
Malaya Mount, MS, RD
CONTACT
860-837-6700
mmount@connecticutchildrens.org

Study Locations (Sites)

Connecticut Children's Medical Center
Hartford, Connecticut, 06107
United States

Collaborators and Investigators

Sponsor: Connecticut Children's Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-10
Study Completion Date2026-03-10

Study Record Updates

Study Start Date2025-03-10
Study Completion Date2026-03-10

Terms related to this study

Keywords Provided by Researchers

  • Glycogen Storage Disease type Ia
  • Blood lactate
  • Glycogen Storage Disease Ia blood glucose
  • GSD I
  • GSDIa
  • Blood glucose
  • Accu chek glucometer
  • Lactate plus

Additional Relevant MeSH Terms

  • Glycogen Storage Disease Type Ia